Axt
Alexandra Axt, Rossdorf DE
Patent application number | Description | Published |
---|---|---|
20080319015 | Insect Repellent Mixture - The present invention relates to the use of an insect repellent, preferably selected from the group 2-(2-hydroxyethyl)-1-methylpropyl 1-piperidinecarboxylate, N,N-diethyl-3-methylbenzamide, dimethyl phthalate, butopyronoxyl, 2,3,4,5-bis(2-butylene)-tetrahydro-2-furaldehyde, N,N-diethylcaprylamide, N,N-diethylbenzamide, o-chloro-N,N-diethylbenzamide, dimethyl carbate, di-n-propyl isocinchomeronate, 2-ethylhexane-1,3-diol, N-octylbicycloheptenedicarboximide or piperonyl butoxide, particularly preferably 2-(2-hydroxyethyl)-1-methylpropyl 1-piperidinecarboxylate, as action enhancer for a second insect repellent, to corresponding compositions, and to the preparation thereof. | 12-25-2008 |
Jakob Axt, Saulheim DE
Patent application number | Description | Published |
---|---|---|
20100070890 | Method for Providing a Manufacturing Execution System (MES) Service to Third Parties - A computer-implemented method for providing on-demand manufacturing execution systems for clients in which a response to a questionnaire from a client with information relative to identification of a business and production process, a determination of process steps, and an identification of process step requirements is evaluated by the service provider according to GUI requirements for each one of a number of individual process steps. Based on the evaluation, a GUI is defined for each of the individual process steps by the service provider and provided to the client for installation on client computing devices in a manufacturing line of the client. Data is collected for each of the individual process steps via each GUI and sent to the service provider for storage and evaluation. | 03-18-2010 |
Peter Axt, Kirkland, WA US
Patent application number | Description | Published |
---|---|---|
20150058175 | REALIZING BOXED EXPERIENCE FOR DIGITAL CONTENT ACQUISITION - Example apparatus and methods concern realizing the boxed experience for digital content acquisition. Example apparatus and methods associate a digital content purchase with digital metadata. The digital content purchase may be a computer game, a console video game, a film, a television program, or an e-book. The digital metadata may describe a user-customizable physical item portrayed within the digital content purchase. Example apparatus and methods include digital metadata with a digital content purchase, and control the re-creation of a physical item from the digital metadata. Example apparatus and methods may limit the number of times the physical item may be re-created from the digital metadata, and may control the frequency with which the physical item may be re-created. | 02-26-2015 |
Sabine Axt, Sunnyvale, CA US
Patent application number | Description | Published |
---|---|---|
20090253787 | SHORT-ACTING SEDATIVE HYPNOTIC AGENTS FOR ANESTHESIA AND SEDATION - The invention provides compounds compositions and methods useful for inducing or maintaining general anesthesia or sedation in mammals. | 10-08-2009 |
20100021395 | CRYSTALLINE FORMS OF A BIPHENYL COMPOUND - The invention provides crystalline forms of biphenyl-2-ylcarbamic acid 1-(2-{[4-(4-carbamoylpiperidin-1-ylmethyl)benzoyl]methylamino}ethyl)piperidin-4-yl ester, and pharmaceutically acceptable solvates thereof. The crystalline form can be a freebase, or a salt such as a diphosphate, monosulfate or dioxalate salt. The invention also provides pharmaceutical compositions comprising these crystalline compounds or prepared using these compounds; processes and intermediates for preparing the crystalline compounds; and methods of using these compounds to treat a pulmonary disorder. | 01-28-2010 |
20100048622 | CRYSTALLINE FORMS OF A BIPHENYL COMPOUND - The invention provides crystalline forms of biphenyl-2-ylcarbamic acid 1-(2-{[4-(4-carbamoylpiperidin-1-ylmethyl)benzoyl]methylamino}ethyl)piperidin-4-yl ester, and pharmaceutically acceptable solvates thereof. The crystalline form can be a freebase, or a salt such as a diphosphate, monosulfate or dioxalate salt. The invention also provides pharmaceutical compositions comprising these crystalline compounds or prepared using these compounds; processes and intermediates for preparing the crystalline compounds; and methods of using these compounds to treat a pulmonary disorder. | 02-25-2010 |
20130125887 | CRYSTALLINE FORMS OF A BIPHENYL COMPOUND - The invention provides crystalline forms of biphenyl-2-ylcarbamic acid 1-(2-{[4-(4-carbamoylpiperidin-1-ylmethyl)benzoyl]methylamino}ethyl)piperidin-4-yl ester, and pharmaceutically acceptable solvates thereof. The crystalline form can be a freebase, or a salt such as a diphosphate, monosulfate or dioxalate salt. The invention also provides pharmaceutical compositions comprising these crystalline compounds or prepared using these compounds; processes and intermediates for preparing the crystalline compounds; and methods of using these compounds to treat a pulmonary disorder. | 05-23-2013 |
20140288033 | CRYSTALLINE FORMS OF A BIPHENYL COMPOUND - The invention provides crystalline forms of biphenyl-2-ylcarbamic acid 1-(2-{[4-(4-carbamoylpiperidin-1-ylmethyl)benzoyl]methylamino}ethyl)piperidin-4-yl ester, and pharmaceutically acceptable solvates thereof. The crystalline form can be a freebase, or a salt such as a diphosphate, monosulfate or dioxalate salt. The invention also provides pharmaceutical compositions comprising these crystalline compounds or prepared using these compounds; processes and intermediates for preparing the crystalline compounds; and methods of using these compounds to treat a pulmonary disorder. | 09-25-2014 |
20150152054 | CRYSTALLINE FORMS OF A BIPHENYL COMPOUND - The invention provides crystalline forms of biphenyl-2-ylcarbamic acid 1-(2-{[4-(4-carbamoylpiperidin-1-ylmethyl)benzoyl]methylamino}ethyl)piperidin-4-yl ester, and pharmaceutically acceptable solvates thereof. The crystalline form can be a freebase, or a salt such as a diphosphate, monosulfate or dioxalate salt. The invention also provides pharmaceutical compositions comprising these crystalline compounds or prepared using these compounds; processes and intermediates for preparing the crystalline compounds; and methods of using these compounds to treat a pulmonary disorder. | 06-04-2015 |
Stephen Axt, Newmarket CA
Patent application number | Description | Published |
---|---|---|
20140150204 | ASSEMBLY FOR MAINTAINING SEPARATION BETWEEN SPRING ASSEMBLY AND HINGE BRACKET THUS REDUCING INADVERTENT STRIKING - An apparatus comprising: a hinge bracket; a spring assembly configured to operatively interact with the hinge bracket; and a separation assembly being configured to permit relative movement between the hinge bracket and the spring assembly without permitting the spring assembly and the hinge bracket from inadvertently striking against each other, whereby occurrence of unwanted noise associated with the spring assembly and the hinge bracket striking each other is reduced. | 06-05-2014 |
Steven D. Axt, Menlo Park, CA US
Patent application number | Description | Published |
---|---|---|
20100056770 | PREPARATION OF NUCLEOSIDES RIBOFURANOSYL PYRIMIDINES - The present process provides an improved method for the preparation of 4-amino-1-((2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-hydrox-ymethyl-3-methyl-tetrahydro-furan-2-yl)-1H-pyrimidin-2-one of the formula (IV) which is a potent inhibitor of Hepatitis C Virus (HCV) NS5B polymerase. | 03-04-2010 |
Steven Donald Axt, Redwood City, CA US
Patent application number | Description | Published |
---|---|---|
20160122356 | METHODS FOR THE PREPARATION OF RIBOSIDES - Provided are methods of preparing compounds and pharmaceutical compositions for treating Filoviridae virus infections The compounds, compositions, and methods provided are particularly useful for the treatment of Marburg virus, Ebola virus and Cueva virus infections. | 05-05-2016 |